Chemoinformaics analysis of 1-(4-Hydroxyphenyl)-2-(2-pyrrolidinyl) ethanone
| Molecular Weight | 205.257 | nRot | 3 |
| Heavy Atom Molecular Weight | 190.137 | nRig | 12 |
| Exact Molecular Weight | 205.11 | nRing | 2 |
| Solubility: LogS | -1.887 | nHRing | 1 |
| Solubility: LogP | 0.971 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 32.7459 |
| nHD | 2 | BPOL | 16.4861 |
| QED | 0.739 |
| Synth | 2.591 |
| Natural Product Likeliness | 0.765 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.008 |
| HIA | 0.022 |
| CACO-2 | -4.685 |
| MDCK | 0.00000796 |
| BBB | 0.078 |
| PPB | 0.200695 |
| VDSS | 2.342 |
| FU | 0.795036 |
| CYP1A2-inh | 0.159 |
| CYP1A2-sub | 0.642 |
| CYP2c19-inh | 0.109 |
| CYP2c19-sub | 0.3 |
| CYP2c9-inh | 0.018 |
| CYP2c9-sub | 0.215 |
| CYP2d6-inh | 0.391 |
| CYP2d6-sub | 0.831 |
| CYP3a4-inh | 0.021 |
| CYP3a4-sub | 0.23 |
| CL | 14.498 |
| T12 | 0.764 |
| hERG | 0.084 |
| Ames | 0.139 |
| ROA | 0.84 |
| SkinSen | 0.766 |
| Carcinogencity | 0.424 |
| EI | 0.058 |
| Respiratory | 0.452 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.643462 |